Cargando…

Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis

BACKGROUND: The oncogenic role of doublecortin-like kinase 1 (DCLK1) as a putative cancer stem cell (CSC) marker has been clarified in colorectal cancer (CRC). Isoform-specific functions of DCLK1 have shed new light on different functions of DCLK1 short (DCLK1-S) and DCLK1 long (DCLK1-L) isoforms in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalantari, Elham, Razmi, Mahdieh, Tajik, Fatemeh, Asadi-Lari, Mohsen, Ghods, Roya, Madjd, Zahra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206744/ https://www.ncbi.nlm.nih.gov/pubmed/35717205 http://dx.doi.org/10.1186/s12935-022-02632-9

Ejemplares similares

Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis
por: Razmi, Mahdieh, et al.
Publicado: (2021)

Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis
por: Gheytanchi, Elmira, et al.
Publicado: (2023)

Periostin: biology and function in cancer
por: Dorafshan, Shima, et al.
Publicado: (2022)

Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review
por: Razmi, Mahdieh, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on screening and diagnosis of patients with prostate cancer: a systematic review protocol
por: Mostafavi Zadeh, Seyed Mostafa, et al.
Publicado: (2022)

Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol
por: Gheytanchi, Elmira, et al.
Publicado: (2017)

Analysis of the clinical significance of DCLK1(+) colorectal cancer using novel monoclonal antibodies against DCLK1
por: Dai, Tianqi, et al.
Publicado: (2018)

DCLK1 immunoreactivity in colorectal neoplasia
por: Gagliardi, Giuseppe, et al.
Publicado: (2012)

Mechanistic and evolutionary insights into isoform-specific ‘supercharging’ in DCLK family kinases
por: Venkat, Aarya, et al.
Publicado: (2023)

Mechanistic and evolutionary insights into isoform-specific ‘supercharging’ in DCLK family kinases
por: Venkat, Aarya, et al.
Publicado: (2023)

Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines
por: Gheytanchi, Elmira, et al.
Publicado: (2021)

Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer
por: Kalantari, Elham, et al.
Publicado: (2022)

The Association Between Higher Expression of Talin-1 and the Reduced Survival Rate in Ovarian Serous Carcinoma Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2023)

DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis
por: Roy, Badal C., et al.
Publicado: (2021)

DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
por: Mohammadi, Chiman, et al.
Publicado: (2021)

BRCA1 Protein Expression Level and CD44(+)Phenotype in Breast Cancer Patients
por: Madjd, Zahra, et al.
Publicado: (2011)

Correction: DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis
por: Roy, Badal C., et al.
Publicado: (2021)

Do Clinical and Demographic Features of Patients with Upper-Gastrointestinal Cancer Affect their Health-related Quality of Life?
por: Esmaili-Hesari, Ramezan-Ali, et al.
Publicado: (2012)

Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma
por: Sharbatoghli, Mina, et al.
Publicado: (2022)

Overexpression and translocation of dynamin 2 promotes tumor aggressiveness in breast carcinomas
por: Sajed, Roya, et al.
Publicado: (2020)

Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
por: Mohsenzadegan, Monireh, et al.
Publicado: (2022)

Publisher Correction: Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
por: Mohsenzadegan, Monireh, et al.
Publicado: (2022)

Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications
por: O’Connell, Malaney R., et al.
Publicado: (2015)

DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer
por: Vijai, Muthu, et al.
Publicado: (2021)

DCLK1 autoinhibition and activation in tumorigenesis
por: Cheng, Linna, et al.
Publicado: (2021)

Prediction of the treatment response in ovarian cancer: a ctDNA approach
por: Sharbatoghli, Mina, et al.
Publicado: (2020)

Tumor matrix stiffness provides fertile soil for cancer stem cells
por: Safaei, Sadegh, et al.
Publicado: (2023)

Application of RNA Sequencing to identify transcriptome modification by DCLK1 in Colorectal Cancer Cells
por: Li, Lianna, et al.
Publicado: (2019)

Structural Basis of Inhibition of DCLK1 by Ruxolitinib
por: Jang, Dong Man, et al.
Publicado: (2021)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2014)

DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis
por: Kim, Jee-Heun, et al.
Publicado: (2022)

Dendritic cells loaded with exosomes derived from cancer stem cell‐enriched spheroids as a potential immunotherapeutic option
por: Naseri, Marzieh, et al.
Publicado: (2021)

Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
por: Ding, Ling, et al.
Publicado: (2021)

Pleiotropic effects of DCLK1 in cancer and cancer stem cells
por: Chhetri, Dibyashree, et al.
Publicado: (2022)

Upregulation of Ganglioside GD2 Synthase (GD2S), as a New Putative Cancer Stem Cell Marker in Breast Carcinomas
por: Mansoori, Maryam, et al.
Publicado: (2021)

Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases
por: Ali, Naushad, et al.
Publicado: (2015)

Nuclear overexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumors
por: Tajik, Fatemeh, et al.
Publicado: (2023)

Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients
por: Sharbatoghli, Mina, et al.
Publicado: (2022)

Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
por: Bellanger, Aurélie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_431cq7qifliqkphhmi50emg91q